VTRS - Viatris Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.52
|
Rev Est: $3.5B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$15.25
DETAILS
HIGH:
$18.00
LOW:
$12.00
MEDIAN:
$15.50
CONSENSUS:
$15.25
DOWNSIDE:
5.07%
Market Cap:
18.50B
Volume:
14,806,643
Avg Volume:
8,890,861
52 Week Range:
6.85-16.43
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.80
Last Dividend:
$0.48
Exchange:
NASDAQ
Country:
US
Employees:
32,000
IPO Date:
1980-03-17
EPS (TTM):
-0.53
P/E Ratio:
-23.43
Revenue (TTM):
14.74B
Total Assets:
41.50B
Total Debt:
14.31B
Cash & Equiv:
734.80M
Rev Growth (5Y):
5.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
7.2%
ROCE:
-0.2%
Debt/Equity:
0.77
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.67 | $0.62 | +7.9% | $3.8B | $3.6B | +3.8% |
| 2025-08-07 | $0.62 | $0.56 | +11.5% | $3.6B | $3.5B | +3.3% |
| 2025-05-08 | $0.50 | $0.49 | +1.6% | $3.3B | $3.2B | +0.6% |
| 2025-02-27 | $0.54 | $0.61 | -11.5% | $3.5B | $3.6B | -2.0% |
| 2024-11-07 | $0.75 | $0.68 | +10.8% | $3.7B | $3.7B | +0.6% |
| 2024-08-08 | $0.69 | $0.68 | +1.8% | $3.8B | $3.8B | +0.4% |
| 2024-05-09 | $0.67 | $0.67 | -0.4% | $3.7B | $3.7B | -0.7% |
| 2024-02-28 | $0.61 | $0.67 | -9.0% | $3.8B | $3.9B | -0.8% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.74B | 15.43B | 16.26B | 17.89B | 11.95B | 11.50B | 11.43B | 11.91B | 11.08B | 9.43B | 7.72B | 6.91B |
| Net Income | (634.20M) | 54.70M | 2.08B | (1.27B) | (669.90M) | 16.80M | 352.50M | 696.00M | 480.00M | 847.60M | 929.40M | 623.70M |
| EPS | -0.53 | 0.05 | 1.71 | -1.05 | -1.11 | 0.03 | 0.69 | 1.30 | 0.94 | 1.80 | 2.49 | 1.63 |
| Total Assets | 41.50B | 47.69B | 50.02B | 54.84B | 61.55B | 31.26B | 32.73B | 35.81B | 34.73B | 22.27B | 15.82B | 15.29B |
| Total Debt | 14.31B | 18.37B | 19.53B | 23.36B | 26.16B | 12.92B | 13.82B | 14.66B | 15.47B | 7.31B | 8.48B | 8.04B |
| Cash & Equivalents | 734.80M | 991.90M | 1.26B | 701.20M | 844.40M | 475.60M | 388.10M | 292.10M | 998.80M | 1.24B | 225.50M | 291.30M |
| Operating Cash Flow | 2.30B | 2.80B | 3.00B | 3.02B | 1.23B | 1.80B | 2.34B | 2.06B | 2.05B | 2.01B | 1.01B | 1.11B |
| Free Cash Flow | 1.98B | 2.33B | 2.51B | 2.51B | 550.60M | 1.40B | 2.09B | 1.79B | 1.66B | 1.65B | 689.50M | 772.00M |
| FCF per Share | 1.66 | 1.94 | 2.07 | 2.07 | 0.92 | 2.50 | 4.05 | 3.34 | 3.18 | 3.31 | 1.74 | 1.96 |
| Book Value | 18.64B | 20.47B | 21.07B | 20.49B | 22.95B | 11.88B | 12.17B | 13.31B | 11.12B | 9.76B | 3.26B | 2.94B |
| Cash & ST Investments | 1.09B | 1.18B | 1.47B | 935.00M | 1.05B | 584.70M | 449.20M | 418.90M | 1.14B | 1.35B | 284.10M | 408.60M |
| ROC Equity | -0.03 | 0.00 | 0.10 | -0.06 | -0.03 | 0.00 | 0.03 | 0.05 | 0.04 | 0.09 | 0.29 | 0.21 |